← Clinical Evidence

SRC-b4bd66ae9c21 Lo C 2019

Evidence source and scope

Lo C, Arora S, Baig F, et al. Predicting motor, cognitive & functional impairment in Parkinson's. Annals of Clinical and Translational Neurology. 2019. DOI 10.1002/acn3.50853

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1002/acn3.50853

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Lo C, Arora S, Baig F, et al. Predicting motor, cognitive & functional impairment in Parkinson's. Annals of Clinical and Translational Neurology. 2019. DOI 10.1002/acn3.50853

Lo CSY, Arora SS, Baig F, et al. Predicting motor, cognitive & functional impairment in Parkinson's. Annals of Clinical and Translational Neurology. 2019. DOI 10.1002/acn3.50853

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — gait

GaitP107,P135-137:110participants126windows28cognitiveoutcomes18mo,MoCA<26;998featuresAUC.97recordingwise10fold,30featuresclinicLOSOAUC.82;withinperson correlation ignored in10fold;LOSO described as eachrecording;noisolatedgaitablation;validation/feature/sourcechanges notsolevalidationeffect. Source locator: s2MethodsandTable1;s4Table2;s5Table3 Limit: Feature ranking averaged acrossLOSOtrainingmodels before selected30evaluation deserves caution. Recordedwindows aren'tindependentparticipants;report correctlypreserves ambiguity.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance

GaitP107,P135-137:110participants126windows28cognitiveoutcomes18mo,MoCA<26;998featuresAUC.97recordingwise10fold,30featuresclinicLOSOAUC.82;withinperson correlation ignored in10fold;LOSO described as eachrecording;noisolatedgaitablation;validation/feature/sourcechanges notsolevalidationeffect. Source locator: s2MethodsandTable1;s4Table2;s5Table3 Limit: Feature ranking averaged acrossLOSOtrainingmodels before selected30evaluation deserves caution. Recordedwindows aren'tindependentparticipants;report correctlypreserves ambiguity.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

GaitP107,P135-137:110participants126windows28cognitiveoutcomes18mo,MoCA<26;998featuresAUC.97recordingwise10fold,30featuresclinicLOSOAUC.82;withinperson correlation ignored in10fold;LOSO described as eachrecording;noisolatedgaitablation;validation/feature/sourcechanges notsolevalidationeffect. Source locator: s2MethodsandTable1;s4Table2;s5Table3 Limit: Feature ranking averaged acrossLOSOtrainingmodels before selected30evaluation deserves caution. Recordedwindows aren'tindependentparticipants;report correctlypreserves ambiguity.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide